Swiss-based multinational pharmaceutical company, Novartis, is acquiring Mariana Oncology, a US-based preclinical-stage biotechnology company focused on developing radioligand therapies (RLTs) to treat cancers, for US$1bn upfront with up to US$750m…
Switzerland: Novartis to acquire Mariana Oncology for up to US$1.75bn
…
…






